Hilton Worldwide
HLT
320.53
-2.08
-0.64%
Hilton Worldwide
US · HLT
#337 by market cap
Listed 2013
320.53
-2.08
-0.64%
Live - 5344 symbols - heartbeat 36s ago
· 2026-10-08 06:37
Pre-market
312.91
-2.38%
After-hours
320.53
0.00%
Overnight
320.60
+0.02%
- Market cap
- 72.14B
- P/E (TTM)i
- 47.07
- P/Bi
- -11.45
- EPSi
- 6.12
- Div yieldi
- 0.19%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on HLT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.97, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.74% YoY
Margins
- Gross margin
- 28.20%
- Operating margin
- 22.37%
- Net margin
- 12.10%
Key ratios & quality
- Enterprise valuei
- 83.59B
- PEG ratioi
- 9.23
- Altman Z-Scorei
- 2.97
PEG uses trailing P/E against the 3-year net income growth rate (5.10%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.91B | 9.45B | 4.31B | 5.79B | 8.77B | 10.24B | 11.17B | 12.04B |
| Gross profit | 2.25B | 2.44B | 583.00M | 1.66B | 2.70B | 2.93B | 3.06B | 3.40B |
| Selling & admin expenses | 443.00M | 441.00M | 311.00M | 405.00M | 382.00M | 408.00M | 415.00M | 393.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.43B | 1.58B | -119.00M | 1.02B | 2.09B | 2.26B | 2.37B | 2.69B |
| Pretax profit | 1.08B | 1.24B | -924.00M | 560.00M | 1.73B | 1.69B | 1.78B | 2.07B |
| Tax | 309.00M | 358.00M | -204.00M | 153.00M | 477.00M | 541.00M | 244.00M | 611.00M |
| Net profit | 769.00M | 886.00M | -720.00M | 407.00M | 1.26B | 1.15B | 1.54B | 1.46B |
| Basic EPS | 3 | 3 | -3 | 1 | 5 | 4 | 6 | 6 |
| Diluted EPS | 2.50 | 3.04 | -2.58 | 1.46 | 4.53 | 4.33 | 6.14 | 6.12 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.70B | 3.14B | 3.12B | 3.09B | 2.94B | 3.34B |
| Gross profit | 697.00M | 956.00M | 941.00M | 801.00M | 853.00M | 1.07B |
| Selling & admin expenses | 94.00M | 109.00M | 95.00M | 95.00M | 103.00M | 114.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 536.00M | 778.00M | 777.00M | 602.00M | 678.00M | 858.00M |
| Pretax profit | 410.00M | 629.00M | 604.00M | 429.00M | 518.00M | 680.00M |
| Tax | 110.00M | 187.00M | 183.00M | 131.00M | 135.00M | 198.00M |
| Net profit | 300.00M | 442.00M | 421.00M | 298.00M | 383.00M | 482.00M |
| Basic EPS | 1 | 2 | 2 | 1 | 2 | 2 |
| Diluted EPS | 1.23 | 1.84 | 1.78 | 1.27 | 1.66 | 2.10 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.98B | 2.09B | 4.20B | 2.87B | 2.87B | 2.61B | 3.27B | 3.00B |
| Cash & ST investments | 403.00M | 538.00M | 3.22B | 1.43B | 1.21B | 800.00M | 1.30B | 918.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 14.00B | 14.96B | 16.76B | 15.44B | 15.51B | 15.40B | 16.52B | 16.77B |
| Total current liabilities | 2.62B | 2.87B | 2.43B | 3.02B | 3.37B | 3.72B | 4.70B | 4.51B |
| Short-term debt | 16.00M | 170.00M | 226.00M | 194.00M | 151.00M | 155.00M | 535.00M | 25.00M |
| Long-term debt | 7.06B | 7.75B | 10.24B | 8.56B | 8.71B | 9.16B | 10.62B | 12.34B |
| Total liabilities | 13,437,000,000.00 | 15,429,000,000.00 | 18,241,000,000.00 | 16,260,000,000.00 | 16,610,000,000.00 | 17,748,000,000.00 | 20,211,000,000.00 | 22,120,000,000.00 |
| Total equity | 558.00M | -472.00M | -1.49B | -819.00M | -1.10B | -2.35B | -3.69B | -5.35B |
| Retained earnings | -6.42B | -5.97B | -6.73B | -6.32B | -5.19B | -4.21B | -2.82B | -1.51B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.76B | 2.47B | 3.12B | 3.00B | 2.77B | 3.30B |
| Cash & ST investments | 731.00M | 371.00M | 1.06B | 918.00M | 564.00M | 1.01B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 16.04B | 15.90B | 16.64B | 16.77B | 16.39B | 16.93B |
| Total current liabilities | 4.84B | 4.59B | 4.70B | 4.51B | 4.56B | 5.08B |
| Short-term debt | 535.00M | 35.00M | 35.00M | 25.00M | 25.00M | 624.00M |
| Long-term debt | 10.62B | 10.91B | 11.60B | 12.34B | 12.33B | 12.72B |
| Total liabilities | 20,382,000,000.00 | 20,453,000,000.00 | 21,532,000,000.00 | 22,120,000,000.00 | 22,252,000,000.00 | 23,198,000,000.00 |
| Total equity | -4.34B | -4.55B | -4.89B | -5.35B | -5.87B | -6.27B |
| Retained earnings | -2.56B | -2.16B | -1.77B | -1.51B | -1.16B | -710.00M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.26B | 1.38B | 708.00M | 109.00M | 1.68B | 1.95B | 2.01B | 2.13B |
| Depreciation & amortization | 325.00M | 346.00M | 331.00M | 188.00M | 162.00M | 147.00M | 146.00M | 177.00M |
| Free cash flow | 1.10B | 1.18B | 616.00M | 30.00M | 1.58B | 1.70B | 1.82B | 1.94B |
| Dividends paid | -181.00M | -172.00M | -42.00M | 0 | -123.00M | -158.00M | -150.00M | -143.00M |
| Stock buybacks / issuance | -1.72B | -1.54B | -296.00M | 0 | -1.59B | -2.34B | -2.89B | -3.18B |
| Ending cash balance | 484.00M | 630.00M | 3.26B | 1.51B | 1.29B | 875.00M | 1.38B | 970.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 452.00M | 658.00M | 816.00M | 203.00M | 618.00M | 472.00M |
| Depreciation & amortization | 41.00M | 43.00M | 46.00M | 47.00M | 50.00M | 49.00M |
| Free cash flow | 412.00M | 615.00M | 766.00M | 151.00M | 587.00M | 435.00M |
| Dividends paid | -37.00M | -36.00M | -35.00M | -35.00M | -35.00M | -34.00M |
| Stock buybacks / issuance | -875.00M | -769.00M | -759.00M | -779.00M | -821.00M | -966.00M |
| Ending cash balance | 807.00M | 448.00M | 1.13B | 970.00M | 619.00M | 1.06B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 58.25 | 2,553.62 | -- | -- | -- | -- | -- | -- |
| ROA %i | 5.40 | 6.09 | -4.51 | 2.55 | 8.11 | 7.38 | 9.62 | 8.75 |
| ROIC %i | 12.46 | 14.24 | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | 28.69 | 536.46 | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.27 | 17.54 | -11.49 | 16.53 | 24.50 | 21.07 | 21.05 | 22.36 |
| FCF / sales %i | 12.31 | 12.47 | 14.30 | 0.52 | 18.00 | 16.60 | 16.24 | 16.15 |
| Current ratioi | 0.76 | 0.73 | 1.73 | 0.95 | 0.85 | 0.70 | 0.70 | 0.66 |
| Quick ratioi | 0.59 | 0.63 | 1.64 | 0.83 | 0.75 | 0.61 | 0.61 | 0.58 |
| Debt / assetsi | 52.03 | 61.26 | 69.40 | 63.31 | 62.47 | 65.71 | 71.94 | 78.06 |
| LT debt / equityi | 1,318.69 | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 3.91 | 4.00 | -1.15 | 2.41 | 5.18 | 4.65 | 4.13 | 4.34 |
| Revenue CAGR (3Y) %i | 7.68 | 12.86 | -19.09 | -13.38 | -2.45 | 33.45 | 24.52 | 11.13 |
| Net income CAGR (3Y) %i | -18.36 | 37.62 | -- | -18.74 | 12.52 | -- | 55.28 | 5.10 |
| FCF CAGR (3Y) %i | 1.86 | 8.94 | -4.89 | -69.86 | 10.23 | 40.24 | 292.57 | 7.18 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 9.82 | 10.04 | 9.99 | 8.75 | 9.51 | 9.65 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.34 | 21.42 | 22.08 | 22.36 | 22.94 | 23.23 |
| FCF / sales %i | 16.95 | 18.70 | 19.57 | 16.15 | 17.25 | 15.53 |
| Current ratioi | 0.57 | 0.54 | 0.66 | 0.66 | 0.61 | 0.65 |
| Quick ratioi | 0.48 | 0.45 | 0.58 | 0.58 | 0.49 | 0.55 |
| Debt / assetsi | 74.05 | 73.52 | 74.22 | 78.06 | 79.69 | 82.84 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 4.14 | 4.15 | 4.23 | 4.34 | 4.42 | 4.33 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Cost reimbursement revenues is the largest reported line at 59.32% of revenue, across 6 reported segments.
- Management and franchise follows at 30.20%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Cost reimbursement revenues59.32%
Management and franchise30.20%
Ownership9.31%
Other revenues2.16%
Quote time 2026-10-08 06:37:08 · For reference only, not investment advice and not tailored to your situation.